47 employees in Hoover, AL are covered by the one WARN layoff or closure notice Biocryst Pharmaceuticals Inc has on file as of November 6, 2026, dated August 4, 2026, effective October 7, 2026. Biocryst Pharmaceuticals Inc also reported 2 exit or restructuring plans to the SEC on Form 8-K (Alabama WARN notice, August 4, 2026).
Who owns BioCryst Pharmaceuticals, Inc.?
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Biocryst Pharmaceuticals Inc.
Free to see. No signup.
Biocryst Pharmaceuticals Inc filed 1 WARN notice in Alabama, covering 47 employees in total. Each notice below links to the state file it was published in.
Did Biocryst Pharmaceuticals Inc have layoffs in 2026? Every notice
| Notice | Where | Employees | Type | Effective | Days' notice | Source |
|---|---|---|---|---|---|---|
| 2026-08-04 | Hoover, AL | 47 | closure | 2026-10-07 | 64 | AL file |
Keep reading
More on Biocryst Pharmaceuticals Inc and the records around it.
Biocryst Pharmaceuticals Inc elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Deerfield Mgmt, L.P. also filed stake reports on 19 other companies: Climb Bio, Inc. (Oct 2026), Cogent Biosciences, Inc. (Aug 2026), Enhabit, Inc. (Aug 2026)
- RA Capital Management, L.P. also filed stake reports on 100 other companies: Climb Bio, Inc. (Nov 2026), Bambusa Therapeutics, Inc. (Nov 2026), SOLID BIOSCIENCES INC. (Nov 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
Watch Biocryst Pharmaceuticals Inc
Get an email when Biocryst Pharmaceuticals Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Biocryst Pharmaceuticals Inc?
Want the whole picture on Biocryst Pharmaceuticals Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biocryst Pharmaceuticals Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biocryst Pharmaceuticals Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
SEC filings: exit or restructuring (Item 2.05)
Biocryst Pharmaceuticals Inc (CIK 882796) reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written. These filings are matched to the WARN notices above on the company's exact name.
Form 8-K/A filed 2026-08-04
Locations
On June 29, 2026, the Company announced its plan to discontinue the Company's internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the "Plan") as part of the Company's ongoing strategic evolution to strengthen its rare disease pipeline.
Expected charges
The Company now estimates that it will incur between $6.2 and $7.5 million in one-time expenses in connection with employee termination benefits and severance, of which approximately $5.3 to $6.6 million are expected to be cash expenditures.
Form 8-K filed 2026-06-29
Locations
On June 25, 2026, the Board of Directors of BioCryst Pharmaceuticals, Inc. (the "Company") approved a plan to discontinue the Company's internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the "Plan").
Timing
The implementation of the Plan is expected to be substantially complete by the end of 2026.
Also on the record for Biocryst Pharmaceuticals Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by RA Capital Management, L.P. | 6.2% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 6% of the class | 5%+ stakes | Source |
| May 12, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 4.9% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.16% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Deerfield Mgmt, L.P. | 6.81% of the class | 5%+ stakes | Source |
| February 9, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.3% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G, by RA Capital Management, L.P. | 7.3% of the class | 5%+ stakes | Source |
| September 19, 2025 | Stake report, Schedule 13G, by Deerfield Mgmt, L.P. | 5.8% of the class | 5%+ stakes | Source |
Tools for this story
Each opens in a new tab, filled in for Biocryst Pharmaceuticals Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Related
- Comcast: 902 jobs, Oct 2026 layoff notice within 90 days (2026-10-29)
- Cayuga Home for Children: 504 jobs, Oct 2026 layoff notice within 90 days (2026-10-05)
- Endeavors: 124 jobs, FL and more, Oct 2026 layoff notice within 90 days (2026-10-29)
- Amazon: 9,003 jobs, Nov 2026 layoff notice within 90 days (2026-11-02)
- General Dynamics Information Technology: 874 jobs, Oct 2026 layoff notice within 90 days (2026-10-30)
- Amentum: 1,112 jobs, Sep 2026 layoff notice within 90 days (2026-09-25)
Cite this page
https://mentionfox.com/layoffs/biocryst-pharmaceuticals